权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Tailored Screening for Urinary System Cancers in Patients with Chronic Kidney Disease

慢性肾病患者泌尿系统癌症的定制筛查

基本信息

批准号：
10444655
负责人：
Stella Kang
金额：
$ 51.2万
依托单位：
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
依托单位国家：
美国
项目类别：
财政年份：
2022
资助国家：
美国
起止时间：
2022-07-01 至 2027-05-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10444655
关键词：
Accounting Address Adherence Adult Affect Aftercare Age Anatomy Bladder Cancer Burden Cardiovascular Diseases Cardiovascular system Caring Cause of Death Cessation of life Chronic Kidney Failure Classification Clinical Cohort Studies Colorectal Cancer Complex Computer Simulation Data Set Detection Diagnosis Epidemiology Evaluation Event Frequencies General Population Goals Guidelines Health Health Status Hypertension Incidence Internal Medicine K-Series Research Career Programs Kidney Kidney Neoplasms Life Expectancy Link Magnetic Resonance Imaging Malignant Neoplasms Malignant neoplasm of lung Malignant neoplasm of ureter Malignant neoplasm of urinary bladder Modeling Monitor Morbidity - disease rate Natural History Nephrology Obesity Outcome Pathway interactions Patient advocacy Patients Perception Persons Population Population Heterogeneity Practice Guidelines Prevention strategy Primary Health Care Proteinuria Public Health Publishing Quality of life Quality-Adjusted Life Years Radiology Specialty Recommendation Recurrence Renal Cell Carcinoma Renal Mass Renal carcinoma Renal function Risk Risk Factors Science Screening for cancer Severities Severity of illness Smoking Subgroup Testing Time Translating Urinary system Urinary tract Urologic Cancer Urologic Oncology Urology Urothelium Work aged base black men black women cancer risk cardiovascular risk factor clinical practice comorbidity cost cost effective cost effectiveness cost estimate disease natural history experience hazard human old age (65+)improved middle age models and simulation mortality mortality risk patient subsets screening screening guidelines tv watching ultrasound urinary young man

项目摘要

Project Summary Chronic kidney disease (CKD) is a highly prevalent condition, found in 20% of people aged 50 years and older. While it is well known that CKD is strongly associated with cardiovascular mortality, recent work has demonstrated an association with cancer risk that also merits consideration for preventive strategies. Cancer is the leading cause of death in mid-life patients afflicted by early stages of CKD, and the 2nd leading cause across all CKD patients under 65 years. Specifically, kidney cancers occur three times more often in patients with CKD, including a hazard ratio of up to 3.4 in younger men (40-52 years) with moderate CKD (15-60 mL/min/1.73 m2). Indeed, the incidence of kidney cancer in mid-life patients with CKD is similar to that of colorectal cancer in the general population. Risks of bladder cancer are similarly increased in CKD. Current guidelines recommend that CKD patients undergo monitoring of common renal and cardiovascular risk factors that overlap with those of urinary tract cancers such as smoking, hypertension, and obesity. Thus, the lack of clear cancer screening recommendations represents an important gap in CKD practice guidelines, and may be due to the complex weighing of benefits and harms for a population with wide-ranging health status. Our team of experts in decision science, epidemiology, urologic oncology, nephrology, radiology, and internal medicine will apply complementary experience to assess the potential of screening strategies. We previously developed and published a computer simulation model of kidney tumors and comorbidities, supported by an NCI K award, the Renal Anatomy and Function for Renal Masses (Re-AFFiRM) simulation model. Our model is capable of simulating outcomes of subpopulations defined by CKD severity and kidney tumor natural history. We will transform the model to incorporate bladder cancer natural history as well as kidney and bladder screening pathways. We will assess whether cancer screening pathways benefit life expectancy and quality-adjusted life expectancy based on age, CKD stage, strong co-existing risk factors, and comorbidity burden. Middle-aged adults without other significant cardiovascular comorbidity and multiple established risk factors may warrant more intensive screening, whereas patients with cardiovascular disease and few risk factors may warrant less intensive screening. In addition, Black men and women with CKD have been shown repeatedly to suffer higher all-cause and cancer-specific mortality compared to non-Black CKD patients, an important consideration in forming screening recommendations. Our findings will be evaluated by a group of independent stakeholders in primary care, nephrology, urology, and patient advocacy to consider the acceptability and barriers to screening as supported by the model results. Cost-effectiveness will also be explored for key factors that affect or elevate the value of screening. Our goal will be to establish the context in which urinary tract screening recommendations could benefit the large population with CKD.

项目总结